Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

CSE/NIRV.X stock hub

CSE/NIRV.X has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/NIRV.Xis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

229.2K

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/NIRV.X

In the news

Latest news · CSE/NIRV.X

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/NIRV.X market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

123

Groups with data

Currency

CAD

Showing 123 of 123 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees Change	0%
Employees Change Percent	0
Enterprise value	CAD 364,763
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	CAD 229,233
Price	CAD 0.01
Price currency	CAD
Sic	2834
Symbol	cse/NIRV.X
Website	https://nirvanalifescience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-156.45%
EV Earnings	-1.02x
P/B ratio	-0.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -358,633
ROA	-1,018.4
ROCE	53.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-90.49%
Cagr3y	-72.85%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 20,319
Cash	CAD 1,347
Current Assets	CAD 20,319
Current Liabilities	CAD 643,266
Debt	CAD 142,173
Equity	CAD -709,221
Interest Coverage	-166
Liabilities	CAD 729,540
Long Term Assets	CAD 0
Long Term Liabilities	CAD 86,274
Net Cash	CAD -140,826
Net Cash By Market Cap	CAD -61.43
Tangible Book Value	CAD -703,921
Tangible Book Value Per Share	CAD -0.03
WACC	1.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.03
Net Working Capital	CAD -482,121
Quick ratio	0.03
Working Capital	CAD -622,947

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	38.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-90.48%
200-day SMA	0.49
3Y total return	-98%
50-day SMA	0.17
50-day SMA vs 200-day SMA	50under200
All Time High	9.5
All Time High Change	-99.89%
All Time High Date	2022-03-22
All Time Low	0.01
All Time Low Change	100%
All Time Low Date	2026-02-25
ATR	0.04
Beta	-0.57
Beta1y	-8.25
Beta2y	-2.59
Ch YTD	-86.67
High	0.05
High52	0.14
High52 Date	2025-10-10
High52ch	-92.86%
Low	0.01
Low52	0.01
Low52 Date	2026-04-23
Low52ch	100%
Ma50ch	-94.04%
Price vs 200-day SMA	-97.94%
RSI	41.64
RSI Monthly	30.49
RSI Weekly	40.91
Sharpe ratio	2x
Sortino ratio	6.88
Total Return	38.43%
Tr YTD	-86.67
Tr1m	100%
Tr1w	-75%
Tr3m	-85.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -332,059

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,418,888%
Net Borrowing	56,046
Shares Insiders	11.91%
Shares Out	22,923,301
Shares Qo Q	-0.48%
Shares Yo Y	-38.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,783.35x
Bv Per Share	-0.03
Ch1m	100
Ch1w	-75
Ch1y	-90.48
Ch3m	-85.71
Ch3y	-98
Ch6m	-92.86
Change	-75%
Change From Open	-77.78
Close	0.04
Days Gap	12.5
Dollar Volume	80
Earnings Date	2026-09-08
EBIT	CAD -332,059
EPS	CAD -0.02
F Score	1
Financing CF	1,006,464
Fiscal Year End	April
Is Primary Listing	1
Last Report Date	2026-01-31
Last Split Date	2025-03-24
Last Split Type	Reverse
Ma150	0.34
Ma150ch	-97.02%
Ma20	0.06
Ma20ch	-84.5%
Net CF	8,789
Next Earnings Date	2026-09-08
Open	0.05
Position In Range	12.5
Price Date	2026-04-23
Relative Volume	1.38x
Share Based Comp	15,123
Tr6m	-92.86%
Volume	8,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/NIRV.X pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/NIRV.X stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/NIRV.X?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+11.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-38.4%

Negative means the company is buying back shares.

Technical

CSE/NIRV.X momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

-97.9%

50/200-day relationship not available

Beta (5Y)

-0.57

Less volatile than the market

Sharpe ratio

2.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/NIRV.X

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/NIRV.X stock rating?

cse/NIRV.X is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/NIRV.X analysis?

The full report lives at /stocks/cse/NIRV.X/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/NIRV.X?

The latest report frames cse/NIRV.X around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/NIRV.X page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.